Authors’ Reply – Comments: Serum levels of infliximab in Brazilian patients with Crohn's disease: what are the reasons for differences from previous studies?

Bibliographic Details
Main Authors:	Luis Eduardo Miani Gomes, Francesca Aparecida Ramos da Silva, Lívia Bitencourt Pascoal, Renato Lazarin Ricci, Guilherme Nogueira, Michel Gardere Camargo, Maria de Lourdes Setsuko Ayrizono, João José Fagundes, Raquel Franco Leal
Format:	Article
Language:	English
Published:	Faculdade de Medicina / USP
Series:	Clinics
Online Access:	http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1807-59322019000100405&lng=en&tlng=en

id	doaj-992c22aa1a854de69fa1ebeea5866efe
record_format	Article
spelling	doaj-992c22aa1a854de69fa1ebeea5866efe2020-11-24T21:48:22ZengFaculdade de Medicina / USPClinics1980-53227410.6061/clinics/2019/e1517S1807-59322019000100405Authors’ Reply – Comments: Serum levels of infliximab in Brazilian patients with Crohn's disease: what are the reasons for differences from previous studies?Luis Eduardo Miani GomesFrancesca Aparecida Ramos da SilvaLívia Bitencourt PascoalRenato Lazarin RicciGuilherme NogueiraMichel Gardere CamargoMaria de Lourdes Setsuko AyrizonoJoão José FagundesRaquel Franco Lealhttp://www.scielo.br/scielo.php?script=sci_arttext&pid=S1807-59322019000100405&lng=en&tlng=en
collection	DOAJ
language	English
format	Article
sources	DOAJ
author	Luis Eduardo Miani Gomes Francesca Aparecida Ramos da Silva Lívia Bitencourt Pascoal Renato Lazarin Ricci Guilherme Nogueira Michel Gardere Camargo Maria de Lourdes Setsuko Ayrizono João José Fagundes Raquel Franco Leal
spellingShingle	Luis Eduardo Miani Gomes Francesca Aparecida Ramos da Silva Lívia Bitencourt Pascoal Renato Lazarin Ricci Guilherme Nogueira Michel Gardere Camargo Maria de Lourdes Setsuko Ayrizono João José Fagundes Raquel Franco Leal Authors’ Reply – Comments: Serum levels of infliximab in Brazilian patients with Crohn's disease: what are the reasons for differences from previous studies? Clinics
author_facet	Luis Eduardo Miani Gomes Francesca Aparecida Ramos da Silva Lívia Bitencourt Pascoal Renato Lazarin Ricci Guilherme Nogueira Michel Gardere Camargo Maria de Lourdes Setsuko Ayrizono João José Fagundes Raquel Franco Leal
author_sort	Luis Eduardo Miani Gomes
title	Authors’ Reply – Comments: Serum levels of infliximab in Brazilian patients with Crohn's disease: what are the reasons for differences from previous studies?
title_short	Authors’ Reply – Comments: Serum levels of infliximab in Brazilian patients with Crohn's disease: what are the reasons for differences from previous studies?
title_full	Authors’ Reply – Comments: Serum levels of infliximab in Brazilian patients with Crohn's disease: what are the reasons for differences from previous studies?
title_fullStr	Authors’ Reply – Comments: Serum levels of infliximab in Brazilian patients with Crohn's disease: what are the reasons for differences from previous studies?
title_full_unstemmed	Authors’ Reply – Comments: Serum levels of infliximab in Brazilian patients with Crohn's disease: what are the reasons for differences from previous studies?
title_sort	authors’ reply – comments: serum levels of infliximab in brazilian patients with crohn's disease: what are the reasons for differences from previous studies?
publisher	Faculdade de Medicina / USP
series	Clinics
issn	1980-5322
url	http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1807-59322019000100405&lng=en&tlng=en
work_keys_str_mv	AT luiseduardomianigomes authorsreplycommentsserumlevelsofinfliximabinbrazilianpatientswithcrohnsdiseasewhatarethereasonsfordifferencesfrompreviousstudies AT francescaaparecidaramosdasilva authorsreplycommentsserumlevelsofinfliximabinbrazilianpatientswithcrohnsdiseasewhatarethereasonsfordifferencesfrompreviousstudies AT liviabitencourtpascoal authorsreplycommentsserumlevelsofinfliximabinbrazilianpatientswithcrohnsdiseasewhatarethereasonsfordifferencesfrompreviousstudies AT renatolazarinricci authorsreplycommentsserumlevelsofinfliximabinbrazilianpatientswithcrohnsdiseasewhatarethereasonsfordifferencesfrompreviousstudies AT guilhermenogueira authorsreplycommentsserumlevelsofinfliximabinbrazilianpatientswithcrohnsdiseasewhatarethereasonsfordifferencesfrompreviousstudies AT michelgarderecamargo authorsreplycommentsserumlevelsofinfliximabinbrazilianpatientswithcrohnsdiseasewhatarethereasonsfordifferencesfrompreviousstudies AT mariadelourdessetsukoayrizono authorsreplycommentsserumlevelsofinfliximabinbrazilianpatientswithcrohnsdiseasewhatarethereasonsfordifferencesfrompreviousstudies AT joaojosefagundes authorsreplycommentsserumlevelsofinfliximabinbrazilianpatientswithcrohnsdiseasewhatarethereasonsfordifferencesfrompreviousstudies AT raquelfrancoleal authorsreplycommentsserumlevelsofinfliximabinbrazilianpatientswithcrohnsdiseasewhatarethereasonsfordifferencesfrompreviousstudies
_version_	1725892596155285504

Authors’ Reply – Comments: Serum levels of infliximab in Brazilian patients with Crohn's disease: what are the reasons for differences from previous studies?

Similar Items